Rockwell Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1997
Net Income	-8.42	-8.44	-18.68	-32.67	-30.89	-34.13	Upgrade
Depreciation & Amortization	3.87	3.45	2.59	2.52	2.29	2.65	Upgrade
Share-Based Compensation	0.99	0.93	0.32	0.94	0.48	4.95	Upgrade
Other Operating Activities	-4.36	-5.36	-1.15	-4.32	-1.52	-0.73	Upgrade
Operating Cash Flow	-7.92	-9.41	-16.93	-33.53	-29.64	-27.25	Upgrade
Capital Expenditures	-0.28	-0.28	-0.28	-0.52	-1.05	-0.59	Upgrade
Acquisitions	-12.36	-12.36	0	0	0	0	Upgrade
Change in Investments	4.15	9.6	-2.12	0.83	4.26	-3.41	Upgrade
Other Investing Activities	-	-	-	-	-	-0.75	Upgrade
Investing Cash Flow	-8.49	-3.05	-2.4	0.31	3.21	-4.75	Upgrade
Share Issuance / Repurchase	15.42	14.86	15.02	0.1	42.92	22.23	Upgrade
Debt Issued / Paid	-3.27	-3.51	-13.68	-2.28	20.39	-1.15	Upgrade
Other Financing Activities	-0.01	-0.01	14.81	-	-	-	Upgrade
Financing Cash Flow	12.15	11.34	16.15	-2.18	63.32	21.09	Upgrade
Exchange Rate Effect	-0	-0	-0	0	0	0	Upgrade
Net Cash Flow	-4.25	-1.12	-3.18	-35.4	36.89	-10.92	Upgrade
Free Cash Flow	-8.19	-9.7	-17.21	-34.06	-30.69	-27.84	Upgrade
Free Cash Flow Margin	-9.46%	-11.60%	-23.64%	-54.99%	-49.34%	-45.42%	Upgrade
Free Cash Flow Per Share	-0.28	-0.42	-1.20	-3.99	-4.46	-5.03	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).